The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

flyvax.com

Stage

Series A | Alive

Total Raised

$5.4M

Last Raised

$4.6M | 8 yrs ago

About TNG Pharmaceuticals

TNG Pharmaceuticals is furthering the development of a patented vaccine, FlyVax. FlyVax is a veterinary vaccine that is expected to inhibit the horn fly's ability to effectively feed on cattle. FlyVax counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The horn fly's inability to feed thus directly affects reproduction capabilities, leading to the potential systematic eradication of horn fly populations. Smaller horn fly populations can directly translate into lower infestations per cow which leads to less stress, more weight, and more milk yield.

TNG Pharmaceuticals Headquarter Location

201 E Jefferson Street Suite 201

Louisville, Kentucky, 40202,

United States

888-345-0878

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

TNG Pharmaceuticals Patents

TNG Pharmaceuticals has filed 1 patent.

The 3 most popular patent topics include:

  • Ribosomal proteins
  • Transcription factors
  • Vaccination
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/13/2018

Vaccines, Ribosomal proteins, Vaccination, Transcription factors, Virology

Application

Application Date

12/13/2018

Grant Date

Title

Related Topics

Vaccines, Ribosomal proteins, Vaccination, Transcription factors, Virology

Status

Application

Latest TNG Pharmaceuticals News

Transgene SA TNG Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27082018 Prices from USD $250

Nov 7, 2018

09:02 EST 7 Nov 2018 | BioPortfolio Reports Summary Transgene SA Transgene, a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases . The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targeted immunotherapeutics utilizing a broad range of viral vectors. Transgene also concentrates on discovery of a novel approach to improve digestion of DNA impurities in the manufacturing of viral vectors. The company operates through collaborations with numerous reference clinical centers, university hospitals and medical centers. It has operations in France, the US and China. Transgene is headquartered in IllkirchGraffenstaden, France. Transgene SA TNG Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

  • Where is TNG Pharmaceuticals's headquarters?

    TNG Pharmaceuticals's headquarters is located at 201 E Jefferson Street, Louisville.

  • What is TNG Pharmaceuticals's latest funding round?

    TNG Pharmaceuticals's latest funding round is Series A.

  • How much did TNG Pharmaceuticals raise?

    TNG Pharmaceuticals raised a total of $5.4M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.